Ignite Creation Date:
2024-05-05 @ 11:54 AM
Last Modification Date:
2024-10-26 @ 9:15 AM
Study NCT ID:
NCT00165386
Status:
COMPLETED
Last Update Posted:
2009-12-09
First Post:
2005-09-09
Brief Title:
MRI-guided Bone Marrow Biopsies of Prostate Cancer Patients
Sponsor:
Dana-Farber Cancer Institute
Organization:
Dana-Farber Cancer Institute
Study Overview
Official Title:
MRI-guided Bone Marrow Biopsies of Advanced CaP Patients
Status:
COMPLETED
Status Verified Date:
2009-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to target lesions of the prostate in the bone and to biopsy these lesions using MRI to identify the areas
Detailed Description:
This study involves a one-time MRI-guided bone marrow biopsy Prior to this procedure patients will need to have a bone scan performed within the last three months and a PSA blood test drawn within one month of registration to the study
Patients are also required to participate in the DFCI research study Collection of Specimens and Clinical Data for Patients with Prostate Cancer or at High Risk for Prostate Cancer
Patients are also required to participate in the DFCI research study Collection of Specimens and Clinical Data for Patients with Prostate Cancer or at High Risk for Prostate Cancer
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None